Berry Genomics Co., Ltd. engages in the gene detection and sales of equipment and reagents of high-throughput sequencing technology. Its products and services include reproductive health, genetic disease testing, tumor detection, technology services, big data services, equipment & reagents, big data services and overall laboratory solution. The company was founded by Yang Gao, Dai Xing Zhou and Ying Hou on April 14, 1997 and is headquartered in Beijing, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company